Many cancer treatments have a dark side—they can damage the heart. New research suggests this risk might be lowered in women with breast tumors if they take a heart drug as a preventive measure during their cancer care.
Nov 11, 2015
0
19
After more than a decade of research and development, researchers in the Department of Radiation Oncology at the University of Maryland School of Medicine will begin enrolling patients in the first clinical trial of GammaPod, ...
Oct 15, 2015
0
7
Accelerated partial breast irradiation was designed to be a faster, more convenient and potentially safer way for many women with breast cancer to reduce their mortality risk and help keep their cancer from returning after ...
Oct 9, 2015
0
11
Decades of research have shown that cancer survival outcomes can vary widely depending on where patients receive care. But efforts to rank hospitals by long-term survival rates have been hindered by the readily available ...
Oct 8, 2015
0
8
How much does your baby weigh? All new parents are familiar with that question. Perhaps their reply is more important than we realize. Birth weight affects how much trust an individual will have in other people in his adult ...
Sep 28, 2015
0
13
Many women with early-stage breast cancer can skip chemotherapy without hurting their odds of beating the disease—good news from a major study that shows the value of a gene-activity test to gauge each patient's risk.
Sep 28, 2015
0
326
Patients with cancers of the mid- and lower throat may have higher survival rates if their initial treatment includes surgery, according to new research presented to the 2015 European Cancer Congress today.
Sep 25, 2015
0
6
The publication of the Eighth Edition of the Tumor, Node and Metastasis (TNM) Classification of Lung Cancer will provide physicians around the world access to new data to more precisely stage and treat cases of lung cancer. ...
Sep 8, 2015
0
7
(HealthDay)—Physicians whose peers were early adopters of brachytherapy for the treatment of women with early-stage breast cancer are more likely to adopt the therapy themselves, according to a study published in the Aug. ...
Aug 31, 2015
0
6
Final results of the randomized intergroup EORTC, LYSA (Lymphoma Study Association), FIL (Fondazione Italiana Linfomi) H10 trial presented at the 13th International Conference on Malignant Lymphoma in Lugano, Switzerland, ...
Jul 15, 2015
0
7
